Leleu-Chavain N - Search Results

1

Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.

Rivoal M, Dubuquoy L, Millet R, Leleu-Chavain N. Rivoal M, et al. Among authors: leleu chavain n. J Med Chem. 2023 Nov 9;66(21):14391-14410. doi: 10.1021/acs.jmedchem.3c00593. Epub 2023 Oct 19. J Med Chem. 2023. PMID: 37857324 Review.

2

Recent advances in the development of selective CB(2) agonists as promising anti-inflammatory agents.

Leleu-Chavain N, Body-Malapel M, Spencer J, Chavatte P, Desreumaux P, Millet R. Leleu-Chavain N, et al. Curr Med Chem. 2012;19(21):3457-74. doi: 10.2174/092986712801323207. Curr Med Chem. 2012. PMID: 22709008 Review.

3

Design, synthesis and biological evaluation of potent FAAH inhibitors.

Tuo W, Leleu-Chavain N, Barczyk A, Renault N, Lemaire L, Chavatte P, Millet R. Tuo W, et al. Bioorg Med Chem Lett. 2016 Jun 1;26(11):2701-5. doi: 10.1016/j.bmcl.2016.04.004. Epub 2016 Apr 23. Bioorg Med Chem Lett. 2016. PMID: 27117424

4

Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.

Tuo W, Leleu-Chavain N, Spencer J, Sansook S, Millet R, Chavatte P. Tuo W, et al. Among authors: leleu chavain n. J Med Chem. 2017 Jan 12;60(1):4-46. doi: 10.1021/acs.jmedchem.6b00538. Epub 2016 Nov 14. J Med Chem. 2017. PMID: 27766867 Review.

5

One- or Two-Step Synthesis of C-8 and N-9 Substituted Purines.

Bollier M, Klupsch F, Six P, Dubuquoy L, Azaroual N, Millet R, Leleu-Chavain N. Bollier M, et al. Among authors: leleu chavain n. J Org Chem. 2018 Jan 5;83(1):422-430. doi: 10.1021/acs.joc.7b02269. Epub 2017 Dec 14. J Org Chem. 2018. PMID: 29192784

6

Development of novel oxazolo[5,4-d]pyrimidines as competitive CB₂ neutral antagonists based on scaffold hopping.

Tuo W, Bollier M, Leleu-Chavain N, Lemaire L, Barczyk A, Dezitter X, Klupsch F, Szczepanski F, Spencer J, Chavatte P, Millet R. Tuo W, et al. Among authors: leleu chavain n. Eur J Med Chem. 2018 Feb 25;146:68-78. doi: 10.1016/j.ejmech.2018.01.034. Epub 2018 Jan 16. Eur J Med Chem. 2018. PMID: 29360044

7

Synthesis and biological evaluation of ferrocene-based cannabinoid receptor 2 ligands.

Sansook S, Tuo W, Bollier M, Barczyk A, Dezitter X, Klupsch F, Leleu-Chavain N, Farce A, Tizzard GJ, Coles SJ, Spencer J, Millet R. Sansook S, et al. Among authors: leleu chavain n. Future Med Chem. 2018 Mar 1;10(6):631-638. doi: 10.4155/fmc-2017-0200. Epub 2018 Feb 8. Future Med Chem. 2018. PMID: 29419319 Free article.

8

Benzo[d]thiazol-2(3H)-ones as new potent selective CB₂ agonists with anti-inflammatory properties.

Leleu-Chavain N, Baudelet D, Heloire VM, Rocha DE, Renault N, Barczyk A, Djouina M, Body-Malapel M, Carato P, Millet R. Leleu-Chavain N, et al. Eur J Med Chem. 2019 Mar 1;165:347-362. doi: 10.1016/j.ejmech.2018.12.008. Epub 2018 Dec 13. Eur J Med Chem. 2019. PMID: 30583970

9

Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction.

Le Biannic R, Magnez R, Klupsch F, Leleu-Chavain N, Thiroux B, Tardy M, El Bouazzati H, Dezitter X, Renault N, Vergoten G, Bailly C, Quesnel B, Thuru X, Millet R. Le Biannic R, et al. Among authors: leleu chavain n. Eur J Med Chem. 2022 Jun 5;236:114343. doi: 10.1016/j.ejmech.2022.114343. Epub 2022 Apr 4. Eur J Med Chem. 2022. PMID: 35429911

10

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

Tourteau A, Andrzejak V, Body-Malapel M, Lemaire L, Lemoine A, Mansouri R, Djouina M, Renault N, El Bakali J, Desreumaux P, Muccioli GG, Lambert DM, Chavatte P, Rigo B, Leleu-Chavain N, Millet R. Tourteau A, et al. Bioorg Med Chem. 2013 Sep 1;21(17):5383-94. doi: 10.1016/j.bmc.2013.06.010. Epub 2013 Jun 15. Bioorg Med Chem. 2013. PMID: 23849204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page